Document is current
Any future updates will be listed below
-
Authors
Goldstein, Jill M. https://orcid.org/0000-0003-1689-7791
Konishi, Kyoko
Aroner, Sarah
Lee, Hang
Remington, Anne
Chitnis, Tanuja
Buka, Stephen L.
Hornig, Mady https://orcid.org/0000-0001-7572-3092
Tobet, Stuart A. https://orcid.org/0000-0002-1615-7331
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH090291, MH118919, MH118919)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (AG067019, AG057505, K01AG081500)
U.S. Department of Health & Human Services | NIH | Office of Research on Women's Health (K12HD051959)
- License Information
-
More Information
Article History
Received: 7 August 2023
Revised: 10 October 2024
Accepted: 16 October 2024
First Online: 21 November 2024
Competing interests
: JMG is on the scientific advisory board and has an equity interest in Cala Health (a neuromodulation company). JMG’s interests are managed by MGH and MassGeneral Brigham HealthCare in accordance with the conflict of interest policies. However, the work in the study presented here is unrelated thus there is no conflict of interest.
